List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 10 studies with search of: sorbitol
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed A Study of the Safety and Efficacy of Combination Therapy With Morphine, Phenylephrine and Sorbitol in Human Subjects
Condition: Acute Pain
Interventions: Drug: Morphine;   Drug: Sorbitol+Phenylephrine;   Drug: Sorbitol+Phenylephrine+Morphine;   Drug: Sorbitol low concentration+Phenylephrine+Morphine
2 Active, not recruiting Bifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier
Conditions: Dental Caries;   Infectious Diseases
Interventions: Dietary Supplement: Sorbitol;   Dietary Supplement: Xylitol + BB12;   Dietary Supplement: Xylitol
3 Recruiting A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation
Condition: Constipation
Interventions: Drug: Glycerine;   Drug: Docusate sodium and sorbitol rectal solution
4 Not yet recruiting Effect of Xylitol on Oral Microbiota in Children
Condition: Bacterial Infections
Intervention: Dietary Supplement: xylitol
5 Unknown  Effect of Erythritol and Xylitol on Dental Caries Prevention in Children
Condition: Dental Caries
Interventions: Dietary Supplement: A, erythritol;   Dietary Supplement: xylitol;   Dietary Supplement: C, sorbitol
6 Completed Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)
Conditions: Ocular Hypertension;   Open-Angle Glaucoma
Interventions: Drug: Istalol and Optive;   Drug: Alphagan
7 Terminated Miglustat / OGT 918 in the Treatment of Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: miglustat;   Drug: placebo
8 Not yet recruiting Phase ll Clinical Trial: D-Methionine to Reduce Noise-Induced Hearing Loss (NIHL)
Condition: Noise-Induced Hearing Loss
Interventions: Drug: D-methionine, oral liquid suspension;   Other: Placebo Comparator
9 Not yet recruiting Study of a Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma
Condition: Neuroblastoma Recurrent
Interventions: Drug: Dasatinib;   Drug: Rapamycin;   Drug: Irinotecan;   Drug: Temozolomide
10 Recruiting Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules
Condition: Rotavirus
Interventions: Biological: RotaTeq®;   Biological: Rotarix®

Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options